177 related articles for article (PubMed ID: 26302622)
1. [Pulmonary cytotoxicity induced by bleomycin and methotrexate].
Sheĭkh ZhV; Krutskevich AO; Drebushevskiĭ NS; Shvaĭko SN; Dunaev AP; Alekseev VG
Vestn Rentgenol Radiol; 2015; (3):46-51. PubMed ID: 26302622
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic drug-induced lung disease.
Sostman HD; Matthay RA; Putman CE
Am J Med; 1977 Apr; 62(4):608-15. PubMed ID: 66869
[TBL] [Abstract][Full Text] [Related]
3. [Toxic effects on the lung: is "pneumonia" caused by drugs?].
Bischoff A
MMW Fortschr Med; 2009 Jun; 151(26-29):20-1. PubMed ID: 19739540
[No Abstract] [Full Text] [Related]
4. Review: diagnosis of chemotherapy lung.
Sostman HD; Putman CE; Gamsu G
AJR Am J Roentgenol; 1981 Jan; 136(1):33-40. PubMed ID: 6161531
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary drug toxicity: radiologic and pathologic manifestations.
Rossi SE; Erasmus JJ; McAdams HP; Sporn TA; Goodman PC
Radiographics; 2000; 20(5):1245-59. PubMed ID: 10992015
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary toxicity of antineoplastic drugs.
Willson JK
Cancer Treat Rep; 1978 Dec; 62(12):2003-8. PubMed ID: 87268
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced lung disease.
Limper AH
Clin Chest Med; 2004 Mar; 25(1):53-64. PubMed ID: 15062597
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin induced pulmonary toxicity in patients with germ cell tumours.
Usman M; Faruqui ZS; ud Din N; Zahid KF
J Ayub Med Coll Abbottabad; 2010; 22(3):35-7. PubMed ID: 22338413
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of lung damage due to bleomycin using computed tomography.
Bellamy EA; Nicholas D; Husband JE
Br J Radiol; 1987 Dec; 60(720):1205-9. PubMed ID: 2446690
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary complications of cytostatic medication.
Meinesz D; Seldenrath JJ
Radiol Clin Biol; 1973; 42(2):175-6. PubMed ID: 4124586
[No Abstract] [Full Text] [Related]
11. [Pulmonary alterations in Hodgkin lymphoma].
Jóna Á; Illés Á; Szemes K; Miltényi Z
Orv Hetil; 2016 Jan; 157(5):163-73. PubMed ID: 26801361
[TBL] [Abstract][Full Text] [Related]
12. Altered lung motion is a sensitive indicator of regional lung disease.
Fouras A; Allison BJ; Kitchen MJ; Dubsky S; Nguyen J; Hourigan K; Siu KK; Lewis RA; Wallace MJ; Hooper SB
Ann Biomed Eng; 2012 May; 40(5):1160-9. PubMed ID: 22189492
[TBL] [Abstract][Full Text] [Related]
13. The histopathology of pulmonary reactions to drugs.
Smith GJ
Clin Chest Med; 1990 Mar; 11(1):95-117. PubMed ID: 1691070
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary effects of cytotoxic agents other than bleomycin.
Twohig KJ; Matthay RA
Clin Chest Med; 1990 Mar; 11(1):31-54. PubMed ID: 1691069
[TBL] [Abstract][Full Text] [Related]
15. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literature.
Higa GM; AlKhouri N; Auber ML
Pharmacotherapy; 1997; 17(6):1315-21. PubMed ID: 9399618
[TBL] [Abstract][Full Text] [Related]
16. The pulmonary changes of bleomycin toxicity.
Horowitz AL; Friedman M; Smith J; Yagoda A; LaMonte C; Watson RC
Radiology; 1973 Jan; 106(1):65-8. PubMed ID: 4118845
[No Abstract] [Full Text] [Related]
17. The role of screening and monitoring for bleomycin pulmonary toxicity.
Shippee BM; Bates JS; Richards KL
J Oncol Pharm Pract; 2016 Apr; 22(2):308-12. PubMed ID: 25736276
[TBL] [Abstract][Full Text] [Related]
18. Bleomycin lung: computed tomographic observations.
Rimmer MJ; Dixon AK; Flower CD; Sikora K
Br J Radiol; 1985 Nov; 58(695):1041-5. PubMed ID: 2431737
[TBL] [Abstract][Full Text] [Related]
19. The role of chest computed tomography in the diagnosis of drug-related reactions.
Kuhlman JE
J Thorac Imaging; 1991 Jan; 6(1):52-61. PubMed ID: 1703580
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin-induced upper lobe fibrosis: a case report.
Marruchella A; Franco C; Garavaldi G; Uccelli M; Bottrighi P
Tumori; 2002; 88(5):414-6. PubMed ID: 12487562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
